LIC buys over 2% stake in Dr Reddys Labs

4 Oct 2022 , 12:16 PM

Life Insurance Corporation of India (LIC)s shareholding in Dr Reddys Laboratories has Increased from 93,96,801 to 1,27,83,287 equity shares, increasing its shareholding from 5.645% to 7.679%. There is an increase of more than 2% in the holding during the period from 15 June 2022 to 30 September 2022, LIC said in the filing. The shares were bought through the open market at an average cost of Rs 4289.29 per share. Shares of Dr Reddys Labs fell 0.21% to Rs 4410.90 while shares of LIC rose 1.57% to Rs 630.50 on the BSE. Dr Reddys Labs is engaged in providing medicines. The firm operates in three segments: global generics, pharmaceutical services and active ingredients (PSAI) and proprietary products. The drug majors consolidated net profit surged 108% to Rs 1,187.6 crore on 6% rise in net sales to Rs 5,215.40 crore in Q1 FY23 over Q1 FY22. Powered by Capital Market – Live News